BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parry DA, Tamayo-Orrego L, Carroll P, Marsh JA, Greene P, Murina O, Uggenti C, Leitch A, Káposzta R, Merő G, Nagy A, Orlik B, Kovács-Pászthy B, Quigley AJ, Riszter M, Rankin J, Reijns MAM, Szakszon K, Jackson AP; Scottish Genomes Partnership., Members of the Scottish Genome Partnership include. PRIM1 deficiency causes a distinctive primordial dwarfism syndrome. Genes Dev 2020;34:1520-33. [PMID: 33060134 DOI: 10.1101/gad.340190.120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Schmit M, Bielinsky AK. Congenital Diseases of DNA Replication: Clinical Phenotypes and Molecular Mechanisms. Int J Mol Sci 2021;22:E911. [PMID: 33477564 DOI: 10.3390/ijms22020911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Endrakanti M, Saluja S, Ethayathulla AS, Sapra S, Dalal A, Palanichamy JK, Gupta N. A patient with POLA1 splice variant expands the yet evolving phenotype of Van Esch O'Driscoll syndrome. Eur J Med Genet 2021;64:104261. [PMID: 34119699 DOI: 10.1016/j.ejmg.2021.104261] [Reference Citation Analysis]
3 Starokadomskyy P, Escala Perez-Reyes A, Burstein E. Immune Dysfunction in Mendelian Disorders of POLA1 Deficiency. J Clin Immunol 2021;41:285-93. [PMID: 33392852 DOI: 10.1007/s10875-020-00953-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Bainbridge LJ, Teague R, Doherty AJ. Repriming DNA synthesis: an intrinsic restart pathway that maintains efficient genome replication. Nucleic Acids Res 2021;49:4831-47. [PMID: 33744934 DOI: 10.1093/nar/gkab176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhu M, Wu M, Bian S, Song Q, Xiao M, Huang H, You L, Zhang J, Zhang J, Cheng C, Ni W, Zheng W. DNA primase subunit 1 deteriorated progression of hepatocellular carcinoma by activating AKT/mTOR signaling and UBE2C-mediated P53 ubiquitination. Cell Biosci 2021;11:42. [PMID: 33622397 DOI: 10.1186/s13578-021-00555-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
6 Kilkenny ML, Veale CE, Guppy A, Hardwick SW, Chirgadze DY, Rzechorzek NJ, Maman JD, Pellegrini L. Structural basis for the interaction of SARS-CoV-2 virulence factor nsp1 with DNA polymerase α-primase. Protein Sci 2021. [PMID: 34719824 DOI: 10.1002/pro.4220] [Reference Citation Analysis]